Targeting the TGF-β signaling pathway for fibrosis therapy: a patent review (2015–2020)

X Li, Z Ding, Z Wu, Y Xu, H Yao… - Expert Opinion on …, 2021 - Taylor & Francis
Introduction Fibrosis is a serious disease that occurs in many organs, such as kidney, liver
and lung. The deterioration of these organs ultimately leads to death. Due to the complex …
被引用次数：19 相关文章

Targeting the TGF-β signaling pathway for fibrosis therapy: a patent review (2015-2020)

X Li, Z Ding, Z Wu, Y Xu, H Yao… - Expert opinion on …, 2021 - pubmed.ncbi.nlm.nih.gov
Introduction Fibrosis is a serious disease that occurs in many organs, such as kidney, liver
and lung. The deterioration of these organs ultimately leads to death. Due to the complex …

[引用][C] Targeting the TGF-β signaling pathway for fibrosis therapy: a patent review (2015–2020)

X Li, Z Ding, Z Wu, Y Xu, H Yao, K Lin - Expert Opinion on Therapeutic …, 2021 - cir.nii.ac.jp
Targeting the TGF-β signaling pathway for fibrosis therapy: a patent review (2015–2020) |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …

Targeting the TGF-β signaling pathway for fibrosis therapy: a patent review (2015-2020).

X Li, Z Ding, Z Wu, Y Xu, H Yao, K Lin - Expert Opinion on …, 2021 - europepmc.org
Fibrosis is a serious disease that occurs in many organs, such as kidney, liver and lung. The
deterioration of these organs ultimately leads to death. Due to the complex mechanisms of …